Comments are Off
IID2013, Investigative Dermatology, NativeSkin
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Shop – Europe & Middle-East
Shop – Asia & Pacific
Shop – United States & Canada
Terms & Conditions
Immunocompetent human skin for vaccine and drug development
31 May 2022
Dr. Ginhoux joins Genoskin Scientific Advisory Board
12 May 2022
Myeloid Cell Profiling – Naked Immunology Webinar 2
27 April 2022
We are hiring! Join our team as a Lab Operations Manager!
25 March 2022